City
Epaper

Indonesia Covid spike due to Delta variant

By IANS | Updated: June 14, 2021 10:25 IST

Jakarta, June 14 The recent spike in the number of Covid-19 cases in Indonesia's Kudus district of Central ...

Open in App

Jakarta, June 14 The recent spike in the number of Covid-19 cases in Indonesia's Kudus district of Central Java province is due to the highly infectious Delta variant of the virus, an official said.

Central Java Governor Ganjar Pranowo said on Sunday that 86.11 per cent or 62 out of a total of the 72 cases in Kudus emanated from the Delta variant, reports Xinhua news agency.

"The spread of this virus variant is very fast. Three weeks ago Covid-19 in Kudus affected only three sub-districts but today they are happening in 11 sub-districts," Pranowo said.

"Kudus experienced a significant increase in positive cases in a week, jumping more than 30 times from 26 to 929 cases," Wiku Adisasmito, the national Covid-19 task force spokesperson, said.

Kudus has so far recorded 10,525 confirmed cases, with 7,322 recoveries and 861 deaths.

Health Minister Budi Gunadi Sadikin said the Delta variant in Kudus came from Indonesian migrant workers who returned from India.

"We have been taking good care of airports and seaports in Indonesia," said the Minister.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: KudusGanjar pranowoXinhuaJakartaDeltaBatavia
Open in App

Related Stories

InternationalMichigan Shooting: Suspect in Custody After Active Shooter Incident in Delta Township

InternationalIndonesia: Deadly Fire in Central Jakarta Building Kills 20; Search Operations Continue

InternationalJakarta Blast: 54 Injured During Friday Prayers at School Mosque

InternationalMassive Volcanic Eruption at Mount Lewotobi Laki in Indonesia Triggers Red Alert, Flights Cancelled

InternationalMajor UK Railway Stations Hit by Cyber Attack; Network Rail Suspends Wi-Fi Service

Health Realted Stories

HealthMinistry of Social Justice clocks highest-ever Rs 11,810 crore expenditure in FY26

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support

HealthIndia clocks unprecedented foodgrain output, boosts institutional support to farmers

HealthIndia tightens watch on GLP-1 drugs amid safety and misuse concerns

HealthIndia’s millet push receives dual boost at technology and grassroots levels